Cargando…
European survey on valvular heart disease clinical experience from the European Society of Cardiology council on valvular heart disease
AIMS: The aim of this survey is to analyze how current recommendations on valvular heart disease (VHD) management have been adopted. Identifying potential discrepancies between recommendations and everyday clinical practice would enable us to better understand and address the remaining challenges in...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562836/ https://www.ncbi.nlm.nih.gov/pubmed/36262770 http://dx.doi.org/10.1093/ehjopen/oeac054 |
_version_ | 1784808264500772864 |
---|---|
author | Sannino, Anna Campbell, Sarah Grapsa, Julia Modine, Thomas Barbanti, Marco Chambers, John B Zamorano, Jose L Pibarot, Philippe Garbi, Madalina Vannan, Mani Habib, Gilbert Lancellotti, Patrizio |
author_facet | Sannino, Anna Campbell, Sarah Grapsa, Julia Modine, Thomas Barbanti, Marco Chambers, John B Zamorano, Jose L Pibarot, Philippe Garbi, Madalina Vannan, Mani Habib, Gilbert Lancellotti, Patrizio |
author_sort | Sannino, Anna |
collection | PubMed |
description | AIMS: The aim of this survey is to analyze how current recommendations on valvular heart disease (VHD) management have been adopted. Identifying potential discrepancies between recommendations and everyday clinical practice would enable us to better understand and address the remaining challenges in this controversial and complex field. METHODS AND RESULTS: A total of 33 questions, distributed via email to all European Society of Cardiology (ESC) affiliated countries through the newsletter of the ESC council on VHD, were answered by 689 respondents, mainly from tertiary care settings. The results of this survey showed that VHD patients are mostly managed by tertiary care centres, where multi-disciplinary heart teams are frequently a reality. Cardiac computed tomography (CT) is often used in the preprocedural planning of transcatheter interventions, particularly for sizing and deliverability assessment. Echocardiography represents the most widely used imaging modality in the diagnostic, intra-operative and follow-up phase of VHD patients. Cardiac magnetic resonance (CMR) is still largely underused, also for conditions such as mitral annular disjunction, or for the assessment of left ventricle volumes where it is considered as the gold standard, despite 3D volumes by echocardiography having proved good comparability with CMR. As for endocarditis, despite still underused, transesophageal echocardiography (TEE) represents the approach of choice for the diagnosis of native and prosthesis valve endocarditis (up to 46% of the respondents use it). In this context, positron emission tomography-CT is largely underused. CONCLUSION: There is widespread adoption of current recommendation on the evaluation of VHD and these are frequently used to guide patient management. Nonetheless, there are still many discrepancies across centres and countries which need to be addressed with the aim of improving patients’ management and outcomes and ultimately positively impacting on healthcare resources. |
format | Online Article Text |
id | pubmed-9562836 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-95628362022-10-18 European survey on valvular heart disease clinical experience from the European Society of Cardiology council on valvular heart disease Sannino, Anna Campbell, Sarah Grapsa, Julia Modine, Thomas Barbanti, Marco Chambers, John B Zamorano, Jose L Pibarot, Philippe Garbi, Madalina Vannan, Mani Habib, Gilbert Lancellotti, Patrizio Eur Heart J Open Original Article AIMS: The aim of this survey is to analyze how current recommendations on valvular heart disease (VHD) management have been adopted. Identifying potential discrepancies between recommendations and everyday clinical practice would enable us to better understand and address the remaining challenges in this controversial and complex field. METHODS AND RESULTS: A total of 33 questions, distributed via email to all European Society of Cardiology (ESC) affiliated countries through the newsletter of the ESC council on VHD, were answered by 689 respondents, mainly from tertiary care settings. The results of this survey showed that VHD patients are mostly managed by tertiary care centres, where multi-disciplinary heart teams are frequently a reality. Cardiac computed tomography (CT) is often used in the preprocedural planning of transcatheter interventions, particularly for sizing and deliverability assessment. Echocardiography represents the most widely used imaging modality in the diagnostic, intra-operative and follow-up phase of VHD patients. Cardiac magnetic resonance (CMR) is still largely underused, also for conditions such as mitral annular disjunction, or for the assessment of left ventricle volumes where it is considered as the gold standard, despite 3D volumes by echocardiography having proved good comparability with CMR. As for endocarditis, despite still underused, transesophageal echocardiography (TEE) represents the approach of choice for the diagnosis of native and prosthesis valve endocarditis (up to 46% of the respondents use it). In this context, positron emission tomography-CT is largely underused. CONCLUSION: There is widespread adoption of current recommendation on the evaluation of VHD and these are frequently used to guide patient management. Nonetheless, there are still many discrepancies across centres and countries which need to be addressed with the aim of improving patients’ management and outcomes and ultimately positively impacting on healthcare resources. Oxford University Press 2022-09-02 /pmc/articles/PMC9562836/ /pubmed/36262770 http://dx.doi.org/10.1093/ehjopen/oeac054 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Original Article Sannino, Anna Campbell, Sarah Grapsa, Julia Modine, Thomas Barbanti, Marco Chambers, John B Zamorano, Jose L Pibarot, Philippe Garbi, Madalina Vannan, Mani Habib, Gilbert Lancellotti, Patrizio European survey on valvular heart disease clinical experience from the European Society of Cardiology council on valvular heart disease |
title | European survey on valvular heart disease clinical experience from the European Society of Cardiology council on valvular heart disease |
title_full | European survey on valvular heart disease clinical experience from the European Society of Cardiology council on valvular heart disease |
title_fullStr | European survey on valvular heart disease clinical experience from the European Society of Cardiology council on valvular heart disease |
title_full_unstemmed | European survey on valvular heart disease clinical experience from the European Society of Cardiology council on valvular heart disease |
title_short | European survey on valvular heart disease clinical experience from the European Society of Cardiology council on valvular heart disease |
title_sort | european survey on valvular heart disease clinical experience from the european society of cardiology council on valvular heart disease |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562836/ https://www.ncbi.nlm.nih.gov/pubmed/36262770 http://dx.doi.org/10.1093/ehjopen/oeac054 |
work_keys_str_mv | AT sanninoanna europeansurveyonvalvularheartdiseaseclinicalexperiencefromtheeuropeansocietyofcardiologycouncilonvalvularheartdisease AT campbellsarah europeansurveyonvalvularheartdiseaseclinicalexperiencefromtheeuropeansocietyofcardiologycouncilonvalvularheartdisease AT grapsajulia europeansurveyonvalvularheartdiseaseclinicalexperiencefromtheeuropeansocietyofcardiologycouncilonvalvularheartdisease AT modinethomas europeansurveyonvalvularheartdiseaseclinicalexperiencefromtheeuropeansocietyofcardiologycouncilonvalvularheartdisease AT barbantimarco europeansurveyonvalvularheartdiseaseclinicalexperiencefromtheeuropeansocietyofcardiologycouncilonvalvularheartdisease AT chambersjohnb europeansurveyonvalvularheartdiseaseclinicalexperiencefromtheeuropeansocietyofcardiologycouncilonvalvularheartdisease AT zamoranojosel europeansurveyonvalvularheartdiseaseclinicalexperiencefromtheeuropeansocietyofcardiologycouncilonvalvularheartdisease AT pibarotphilippe europeansurveyonvalvularheartdiseaseclinicalexperiencefromtheeuropeansocietyofcardiologycouncilonvalvularheartdisease AT garbimadalina europeansurveyonvalvularheartdiseaseclinicalexperiencefromtheeuropeansocietyofcardiologycouncilonvalvularheartdisease AT vannanmani europeansurveyonvalvularheartdiseaseclinicalexperiencefromtheeuropeansocietyofcardiologycouncilonvalvularheartdisease AT habibgilbert europeansurveyonvalvularheartdiseaseclinicalexperiencefromtheeuropeansocietyofcardiologycouncilonvalvularheartdisease AT lancellottipatrizio europeansurveyonvalvularheartdiseaseclinicalexperiencefromtheeuropeansocietyofcardiologycouncilonvalvularheartdisease |